Biologics development
We work on antibody and recombinant protein programs using stable and transient CHO/HEK expression systems, scale-down models, and process-controlled bioreactors.
ArtProtein is a specialized biologics CDMO growing in a focused way. We combine deep technical work in CHO/HEK development with close interaction with small and mid-size biotechs.
We work on antibody and recombinant protein programs using stable and transient CHO/HEK expression systems, scale-down models, and process-controlled bioreactors.
Our projects involve upstream optimization, purification concepts, and fit-for-purpose analytical strategies that directly support CMC and tech transfer.
We prepare technical documentation, development summaries, and USDA 9CFR–aligned proposals and reports that help clients communicate clearly with regulators and partners.
Scientists and engineers with strong experience in CHO/HEK cell line development, transient expression, and upstream process development for biologics.
People who enjoy connecting process conditions with analytical data, and who think about how work at small scale will behave in process-controlled bioreactors.
Professionals who are comfortable writing and reviewing CMC content, development reports, and USDA 9CFR documentation in a clear, structured way.
If you would like to be considered for future roles or collaboration, please use the contact form to send:
We review expressions of interest on an ongoing basis and will reach out when there is a potential fit with upcoming work.